Eradication of Microorganisms Embedding in Biofilm by a Dose-Dependent Urokinase-Based Catheter Lock Solution in

Jiayi Wang1, Xiaofei Peng2, Wenqing Yin1

  • 1Department of Nephrology, The Second Xiangya Hospital, Central South University, Key Lab of Kidney Disease and Blood Purification in Hunan, Changsha, China.

Blood Purification
|January 15, 2020
PubMed

Insights

Urokinase plasminogen activator (uPA)-based antibiotic lock therapy effectively removes biofilm-forming bacteria from central vein catheters in hemodialysis patients. This uPA-based approach demonstrates safety and superior efficacy in treating catheter-related blood stream infections compared to heparin-based therapy.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Biotechnology

Background:

  • Catheter-related blood stream infection (CRBSI) is a major complication in hemodialysis (HD) patients, associated with significant morbidity and mortality.
  • Antibiotic lock therapy (ABL) is a key treatment for salvaging central vein catheters (CVCs) in CRBSI cases.
  • Urokinase plasminogen activator (uPA)-based ABL offers potential antimicrobial and biofilm-degrading properties for CRBSI treatment.

Purpose of the Study:

  • To evaluate the in vitro effectiveness of uPA-based ABL against microorganisms within biofilms.
  • To assess the in vivo catheter salvage rate in HD patients with CRBSI using uPA-based ABL.

Main Methods:

  • In vitro: Biofilm formation on HD catheters was induced; uPA with/without antibiotics was applied to assess antimicrobial and biofilm removal.
  • In vivo: 86 HD patients with CRBSI were retrospectively analyzed, comparing uPA-based ABL to heparin-based ABL for catheter salvage.

Main Results:

  • uPA demonstrated efficacy against Staphylococcus epidermidis biofilms, with limited regrowth observed.
  • The combination of uPA and antibiotics showed superior antimicrobial and antibiofilm activity in vitro and in vivo compared to uPA alone or heparin-based ABL.
  • uPA-based ABL was safe in HD patients and more effective for coagulase-negative Staphylococci related CRBSI.

Conclusions:

  • Combined uPA and antibiotics effectively eradicate coagulase-negative S. epidermidis biofilms in vitro.
  • uPA-based ABL is a safe and effective therapeutic option for CRBSI in HD patients, outperforming heparin-based ABL.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
125
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
5.4K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
489
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
303
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K